Background Artificial pancreas systems aim to reduce the burden of type 1 diabetes by
automating insulin dosing. These systems link a continuous glucose monitor (CGM) and …

Accurate continuous glucose monitoring (CGM) is essential for fully automated glucose
control in diabetes mellitus type 1. State-of-the-art glucose control systems automatically …

Objective: The artificial pancreas (AP) is an innovative closed-loop system for type 1
diabetes therapy, in which insulin is infused by portable pumps and insulin dosage is …

The state and disturbance estimations are an indispensable part of the state-of-the-art model-
based controllers as related to the artificial pancreas, supporting the decision-making and …

In classical approaches for an artificial pancreas, continuous glucose monitoring (CGM) is
the only measured variable used for insulin dosing and additional control functions. The …

Objective: A fully automated artificial pancreas requires a meal estimator and predictions of
blood glucose levels (BGL) to handle disturbances during meal times, all without relying on …

Closed-loop glucose control has the potential to improve the glycemic control in patients
with diabetes mellitus type 1. Such an artificial pancreas (AP) should keep the user safe …

A method for estimating meal inputs from Continuous Glucose Monitoring (CGM) data is
presented. The method is based on Kalman filtering and hypothesis testing, and provides …

Meal detection is essential for the automatic control of artificial pancreas (AP). In some
studies, dietary has been treated as perturbations, but this is not accurate enough for …

Because of continuous technical progress over the last decades artificial pancreas (AP)
systems have recently become reality for patients with type 1 diabetes (T1D) with first AP …